1. [1] Lotfi Kashani F, Mojtabaee M, Mansor A. Comparison of the effectiveness of cognitive - behavior therapy, methadone therapy, and the combination method on reducing depression in addicts. Knowledge Res Appl Psychol 2013; 54: 19-26. (Persian)

2. [2] Daley A C, Marlatt G A, Lewinson J H, Ruiz P, Millman R B, Langrod J G. Substance abuse (a comprehensive textbook). 4th edit. Boston: Williams & Wilkin. 2005.

3. [3] Dutra L, Stathopoulou G, Basden S L, Otto M W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 87: 165-179. [DOI:10.1176/appi.ajp.2007.06111851] [PMID]

4. [4] McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689-1695. [DOI:10.1001/jama.284.13.1689] [PMID]

5. [5] World Drug Report 2011. United Nations Office for Drug and Crime (UNODC). 2012.

6. [6] Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addiction behavior. New York: Guilford; 1985.

7. [7] Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, et al. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend 2007; 86: 1-21. [DOI:10.1016/j.drugalcdep.2006.05.012] [PMID] [PMCID]

8. [8] Walitzer KS, Dearing RL. Gender differences in alcohol and substance use relapse. Clin Psychol Rev 2006; 26: 128-148. [DOI:10.1016/j.cpr.2005.11.003] [PMID]

9. [9] Narimani M, Zahed A, Golpour R. The relationship between mindfulness, coping styles and emotional intelligence with mental health in students. J Educ Sci 2012; 5: 91-105. (Persian).

10. [10] Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol 2010; 78: 362-374. [DOI:10.1037/a0019172] [PMID] [PMCID]

11. [11] Breslin FC, Zack M, McMain S. An information‐processing analysis of mindfulness: Implications for relapse prevention in the treatment of substance abuse. Clin Psychol Sci Pract 2002; 9: 275-299. [DOI:10.1093/clipsy.9.3.275]

12. [12] Witkiewit K, Marlatt GA, Walker D. Mindfulness-based relapse prevention for Alcohol and substance use dsisorders. J Cogn Psycho Ther Int Quarter 2005; 19: 211-228. [DOI:10.1891/jcop.2005.19.3.211]

13. [13] Hayes SC, Luoma JB, Bond FW, Akihiko M, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006; 44: 1-25. [DOI:10.1016/j.brat.2005.06.006] [PMID]

14. [14] Bowen S, Chawla N, Marlatt G. Mindfulness-based relapse prevention for addictive behaviors: a clinician's guide, Guilford Press. 2011. [DOI:10.1037/t68971-000]

15. [15] Orsillo M, Roemer L, Barlow D H. Integrating acceptance and mindfulness into existing cognitive-behavioral treatment for GAD: a case study. Cognit Behav Pract 2003; 10: 222-230. [DOI:10.1016/S1077-7229(03)80034-2]

16. [16] Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: meta-analytic review. J Consult Clin Psychol 2010; 78: 169-183. [DOI:10.1037/a0018555] [PMID] [PMCID]

17. [17] Azimi A, Makvandhoseini S, Najafi M, Rafieenia P. A comparative study on effectiveness of acceptance and commitment therapy and logotherapy on symptoms of depression, anxiety and stress of women suffering relapsing remitting multiple sclerosis: A randomized controlled trial study. Koomesh 2018; 20: 612-619. (Persian).

18. [18] Kristeller JL, Wolever RQ. Mindfulness-based eating awareness training for treating binge eating disorder: the conceptual foundation. Eat Disord 2011; 19: 49-61. [DOI:10.1080/10640266.2011.533605] [PMID]

19. [19] Kafi M, Afshar H, Moghtadaei K, Ariaporan S, Daghaghzadeh H, Salamat M. Effectiveness of mindfulness-based cognitive-therapy on psychological signs women with irritable bowel syndrome. Koomesh 2014; 15: 255-264. (Persian).

20. [20] Bowen S, Chawla N, Collins SE, Witkiewitz K, Hsu S, Grow J, et al. Mindfulness-based relapse prevention for substance use disorders: A pilot efficacy trial. Substance Abuse 2009; 30: 295-305. [DOI:10.1080/08897070903250084] [PMID] [PMCID]

21. [21] Gifford EV, Kohlenberg BS, Hayes SC, Antonuccio DO, Piasecki MM, Rasmussen-Hall ML, et al. Acceptance-based treatment for smoking cessation. Behav Ther 2004; 35: 689-705. [DOI:10.1016/S0005-7894(04)80015-7]

22. [22] Dragland L. A review of the role of mindfulness-based interventions in the treatment of addiction. Behav Sci Undergrad J 2015; 2: 13-23. [DOI:10.29173/bsuj282]

23. [23] Garland EL, Howard MO. Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research. Addict Sci Clin Pract 2018; 13: 14. [DOI:10.1186/s13722-018-0115-3] [PMID] [PMCID]

24. [24] Priddy SE, Howard MO, Hanley AW, Riquino MR, Friberg-Felsted K, Garland EL. Mindfulness meditation in the treatment of substance use disorders and preventing future relapse: neurocognitive mechanisms and clinical implications. Subst Abuse Rehabil 2018; 9: 103-114. [DOI:10.2147/SAR.S145201] [PMID] [PMCID]

25. [25] Garland EL, Roberts Lewis A, Tronnier CD, Graves R, Kelley K. Mindfulness-oriented recovery enhancement versus CBT for cooccurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial. Behav Res Ther 2016; 77: 7-16. [DOI:10.1016/j.brat.2015.11.012] [PMID] [PMCID]

26. [26] Dakwar E, Mariani JP, Levin FR. Mindfulness impairments in individuals seeking treatment for substance use disorders. Am J Drug Alcohol Abuse 2011; 37: 165-169. [DOI:10.3109/00952990.2011.553978] [PMID] [PMCID]

27. [27] Kiyani A, Ghasemi N, Alipour A. Comparison of the effectiveness of group psychotherapy based on acceptance, commitment and mindfulness on the rate of craving and cognitive management of excitement in glass consumers. Quarterly J Res Addict 2012; 24: 27-35. (Persian).

28. [28] Oraki M, Bayat SH, Khodadust S. Study of effectiveness mindfulness cognitive therapy and marlaat relapse preventive intervention for mental health in male crack addictions. Health Psychol 2012; 1: 21-31. (Persian).

29. [29] Katz D, Toner B. A systematic review of gender differences in the effectiveness of mindfulness-based treatments for substance use disorders. Mindfulness 2013; 4: 318-331. [DOI:10.1007/s12671-012-0132-3]

30. [30] Sancho M, De Gracia M, Rodríguez RC, Mallorquí-Bagué N, Sánchez-González J, Trujols J, et al. Mindfulness-based interventions for the treatment of substance and behavioral addictions: a systematic review. Front Psychiatry 2018; 9: 1-10. [DOI:10.3389/fpsyt.2018.00095] [PMID] [PMCID]

31. [31] De Morton NA. The pedro scale is a valid measure of the methodological quality ofclinical trials: A demographic study. Aust J Physiother 2009; 55: 129-133. [DOI:10.1016/S0004-9514(09)70043-1]

32. [32] Hamedi A, Shahidi Sh, Khademi A. Effectiveness of mindfulness and consultation on reducing injury to prevent recurrence drug use. Quart J Res Addict 2014; 7: 101-118. (Persian)

33. [33] Maredpour A, Najafi M, Amiri F. The effectiveness of prevention of recurrence based on mindfulness in preventing recurrence, craving and self-control in opiate dependent people. Quart J Res Addict 2014; 32: 87-104. (Persian).

34. [34] Dabaghi P, Farbod A, Atef Vahid MK, Bolhari J. The effectiveness of prevention of recurrence based on mindfulness. Quart J Res Addict 2008; 2: 29-44. (Persian).

35. [35] Kaldovi A, Borjali A, Falsafinejad M, Sohrabi F. The effectiveness of a mindfulness prevention model in prevention of return and motivation in opiate addicts. J Clin Psychol 2011; 4: 69-79. (Persian).

36. [36] Yaghubi M, Zargar F, Akbari H. Effectiveness of mindfulness-based relapse prevention on relapse rate in opioid dependents: a randomize control trial. J Res Behav Sci 2016; 14: 472-478. (Persian).

37. [37] Rayan A, Ahmad M. Mindfulness-based intervention: a culturally adaptable intervention in clinical psychology. Clin Psychiatry 2016; 2: 1-20. [DOI:10.21767/2471-9854.100024]

38. [38] Garland EL, Froeliger B, Howard MO. Mindfulness training targets neurocognitive mechanisms of addiction at the attention appraisal-emotion interface. Front Psychiatry 2013; 4: 173-186. [DOI:10.3389/fpsyt.2013.00173] [PMID] [PMCID]

39. [39] Heinz AJ, Epstein DH, Schroeder JR, Singleton EG, Heishman SJ, Preston KL. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. J subst Abus Treat 2006; 31: 355-364. [DOI:10.1016/j.jsat.2006.05.009] [PMID]

40. [40] Rosenberg H. Clinical and laboratory assessment of the subjective experience of drug craving. Clinic Psychol Rev 2009; 29: 519-534. [DOI:10.1016/j.cpr.2009.06.002] [PMID]